Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells

Author: Zhang Xiao-Yu   Zhang Yun-Kai   Wang Yi-Jun   Gupta Pranav   Zeng Leli   Xu Megan   Wang Xiu-Qi   Yang Dong-Hua   Chen Zhe-Sheng  

Publisher: MDPI

E-ISSN: 1420-3049|21|9|1236-1236

ISSN: 1420-3049

Source: Molecules, Vol.21, Iss.9, 2016-09, pp. : 1236-1236

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content